论文信息 - Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). - 字舞流文

Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL).

W. Wilson | L. Chirieac | S. Pittaluga | G. Shapiro | A. Wiestner | K. Dunleavy | J. Janik | E. Jaffe | K. Tay | M. Disinski | W. Wilson